Scientists have new and better way to study the brain and advance treatments.
Alzheimer’s, Parkinsons, ALS, Lewy body dementia, and Huntington’s are terrifying diseases that have taken a devastating toll on families and communities across the world. Despite the urgency and decades of research, we still lack effective treatments for many such conditions. But the Allen Institute's Brain Health accelerator hopes to change that. It’s a global, collaborative research initiative aimed at better understanding the human brain in health and disease to help design new gene therapies that target cell types—rather than molecules—to stop or prevent the drivers of neurodegeneration. Brain Health’s integrated approach draws upon multidisciplinary expertise and is poised to reshape how brain research is done around the world. In this episode of Lab Notes, we speak to some of the researchers behind the science on what makes Brain Health accelerate unique and a powerful new model for global science.
This episode of Lab Notes was produced by Ed Lein, Amity Addrisi, Peter Kim, and Lisa Gray.
Behind every science headline, there is a human story. Hear about the scientific advancements aiming to shape the cures of tomorrow with Lab Notes: A podcast from the Allen Institute. Streaming everywhere.
Weitere Episoden von „Lab Notes“



Verpasse keine Episode von “Lab Notes” und abonniere ihn in der kostenlosen GetPodcast App.








